Should I buy Remgro stock in 2025?

What is Remgro?

How much is Remgro stock?

The price of Remgro stock is rising this week. As of now, Remgro shares are trading at ZAR 16,142, reflecting a 1.62% increase over the past 24 hours and a 3.76% gain for the week.

These figures highlight a positive momentum and moderate volatility, suggesting an appealing opportunity for South African investors seeking growth in a diversified portfolio.

Our complete analysis on the Remgro stock

Having carefully assessed Remgro’s latest financial results alongside its stock performance over the past three years, and after integrating a blend of financial indicators, technical signals, market intelligence, and competitive benchmarking through advanced algorithms, a nuanced picture emerges for this prominent JSE-listed conglomerate. Remgro’s diversified holdings and adaptive strategy are once again drawing investor attention, notably as the company navigates a rapidly shifting South African and global economic landscape. So, why might Remgro stock once again become a strategic entry point into the diversified investment and financial sector in 2025?

Recent Performance and Market Context

Remgro’s share price has demonstrated notable resilience and upward momentum, closing at 16 142 ZAR as of 30 May 2025, reflecting an intraday gain of +1.62% and an impressive 28.32% appreciation over the past year. Not only has the stock posted a 7.94% advance in the last six months, but it is also trading solidly within a bullish channel, outperforming sector averages and signalling renewed market conviction.

Several recent events have buoyed market sentiment. Chief among them is a strong set of interim financial results: Remgro reported a net profit of 3.66 billion ZAR for H2 2024 (a marked turnaround from a 2.00 billion ZAR loss in the prior year’s comparable period) and delivered a 3.9% increase in revenue. The interim dividend was increased by 20%, underpinning management’s confidence in future cash flows.

At the macro level, South Africa’s investment environment is stabilising, with improving GDP growth forecasts for 2025 and renewed commitments to infrastructure, healthcare, and financial reforms. These tailwinds have amplified the appeal of well-diversified holding companies such as Remgro, which stand to capture upside from broad-based economic recovery, both domestically and in their offshore exposures—particularly through Mediclinic’s global footprint and Remgro’s financial services holdings.

Technical Analysis

Technical signals on Remgro are increasingly supportive of an upside scenario. The stock is currently trading above its 15-day moving average—a configuration generally associated with continued momentum. All key moving averages (short-, medium-, and long-term) have consolidated a strong buy signal, as indicated by major technical platforms.

• Relative Strength Index (RSI): Remgro’s RSI currently sits in a neutral but ascending range, suggesting room for further upside before entering overbought territory.
• MACD: The MACD (Moving Average Convergence Divergence) has crossed above its signal line, illustrating a bullish reversal and underlining fresh buying interest.
• Support/Resistance: A firm support zone is established at ~15 800 ZAR, with near-term resistance at the 52-week high of ~16 500 ZAR. Sustained closes above this level could trigger a breakout towards analyst target prices in the 20 700–20 985 ZAR range.
• Momentum: Short-to-medium-term structure remains constructive, underpinned by increasing volume and improving price structure. The overall technical consensus has shifted from “neutral” to “accumulate,” as per aggregated analyst sentiment.

Altogether, the technical landscape signals that Remgro may be entering a new bullish phase, positioning it attractively for both tactical and strategic portfolios.

Fundamental Analysis

Remgro’s latest earnings release marked a decisive inflection in business fundamentals:

• Revenue Growth: Group revenue reached 26.4 billion ZAR for H2 2024, a 3.9% increase over the prior period, while net profit rebounded to 3.66 billion ZAR—signalling powerful operational leverage.
• Profitability: Net margins improved to 14%, and EPS shifted from a loss to 6.59 ZAR, exceeding market expectations by 38.6%.
• Valuation: With a trailing price/earnings ratio of 12.56, Remgro trades at a discount to both its historical averages and comparable diversified financial groups, suggesting the stock’s valuation remains attractive relative to peer benchmarks. The calculated price target of ~20 985 ZAR offers roughly 30% upside.
• Dividends: The current yield (1.76%) has strengthened due to dividend growth, reaffirming Remgro’s capacity for shareholder returns even as it invests for long-term growth.
• Structural Strengths: Remgro’s dominant 28.2% stake in RMB Holdings and participations in FirstRand and Mediclinic assure stable and diversified earnings flows. The group’s disciplined capital allocation, demonstrated by improved returns from Rainbow, RCL Foods, and OUTsurance, adds another layer of strength. Innovative expansion—especially in health care (Mediclinic’s international business) and strategic investments such as the Maziv transaction—augments Remgro’s competitive edge and market share.
• Brand & Leadership: Under Johann Rupert’s stewardship, the group enjoys robust brand equity and an enviable reputation for prudent governance and adaptive strategy.

These foundational elements justify renewed investor interest and reinforce the sense that Remgro’s value proposition is firmly on the ascent.

Volume and Liquidity

Turning to market mechanics, Remgro continues to display robust trading volumes, averaging 681 250 shares daily over the past three months. This liquidity profile underscores sustained institutional and retail interest, fostering a dynamic environment conducive to efficient price discovery.

The free float—currently at 471.27 million shares—supports both liquidity and the potential for upward valuation rerating as investor demand strengthens. Notably, increased turnover during positive earnings surprises and major corporate developments has typically been met with supportive price action, attesting to underlying market confidence.

This combination of healthy trading volume and float aligns well with the profiles most favoured by momentum and long-only investors seeking scalable positions in the South African market.

Catalysts and Positive Outlook

Looking forward, multiple positive catalysts support an optimistic medium- and long-term scenario:

• Strategic Transactions: The anticipated completion of the Maziv/Vodacom transaction and expansion initiatives at Mediclinic signal imminent value-unlocking events.
• Operational Excellence: Ongoing turnaround and margin improvements in Rainbow, RCL Foods, OUTsurance Group and Heineken Beverages (now returned to profit) highlight successful operational execution across the portfolio.
• Capital Allocation: Management’s record of disciplined capital deployment continues to drive intrinsic NAV growth, up 10.3% YoY to 276.89 ZAR per share.
• Sector Trends: With regulatory momentum supporting investment and infrastructure and a growing focus on health, consumer, and financial services, Remgro is well-positioned to benefit from secular trends. Participation in financial platforms (FirstRand, RMB Holdings) and healthcare (Mediclinic) hedge the group’s exposure to cyclical downturns.
• ESG Initiatives: Remgro’s reputation and progress in environmental, social, and governance initiatives further strengthen its competitive positioning and appeal to global allocators.
• Positive Sentiment: The market’s optimistic outlook, reflected by a consensus among analysts’ target prices and favorable technical signals, underscores the conviction that Remgro’s re-rating potential remains far from exhausted.

Overall, these catalysts could offer significant upside for investors prepared to engage ahead of imminent structural inflection points.

Investment Strategies

Given the favourable technicals, fundamentals, and clearly identified catalysts, several strategic considerations emerge:

• Short-Term Entry: Tactical investors may look to accumulate around the current support region (~15 800 ZAR), capitalising on near-term momentum and the prospect of a breakout should the 16 500 ZAR resistance be decisively breached.
• Medium-Term Positioning: Momentum and growth-focused investors may target holdings ahead of the Maziv transaction closure and full-year earnings releases, seeking to benefit from continued operational improvements and portfolio updates, as well as potential positive risk-reward asymmetry tied to Remgro’s growth platforms.
• Long-Term Portfolio Inclusion: For strategic investors, Remgro’s undervalued multiples, portfolio diversification, proven management, and established dividend track record offer compelling reasons to consider gradual accumulation, especially at technically validated lows or on event-driven weakness.
• Risk Management: While macro volatility and regulatory complexities, particularly the Maziv/Vodacom deal, warrant continued monitoring, Remgro’s resilience, strategic capital deployment, and risk mitigation record may serve as reliable buffers against sector idiosyncrasies.

Taken together, these approaches suggest that Remgro could be well-positioned for those targeting stable compounds, tactical upside, or structural participation in South Africa’s economic renaissance.

Is it the right time to buy Remgro?

Remgro’s case for renewed interest rests on its robust recent performance, attractive valuation, accelerated earnings rebound, and diversified exposure to growth sectors—including healthcare, financials, and consumer staples. Technical analysis validates the current momentum, while trading liquidity supports both institutional and retail strategies. With analyst targets implying further material upside, and a series of near-term catalysts on the horizon, the stock seems to represent an excellent opportunity for investors seeking participation in a resilient and adaptive conglomerate at a pivotal junction.

The convergence of compelling fundamentals, constructive technical patterns, and forward-looking strategic initiatives reinforces the notion that Remgro may be entering a new bullish phase. Careful monitoring of transaction outcomes and macroeconomic conditions remains prudent, but the groundwork has been laid for outperformance. At current levels, Remgro appears to offer a rare combination of value, growth, and strategic upside within the JSE landscape.

For those seeking exposure to a cornerstone of South African corporate excellence, fundamentally justified by growing earnings, disciplined capital management, and proven adaptability, Remgro stands out as an investment candidate worthy of serious consideration as momentum builds into 2025. The weeks and months ahead may well define a new chapter for this venerable group, presenting a window of opportunity for discerning investors attuned to structural transformation and revaluation upside.

How to buy Remgro stock in South Africa?

Buying Remgro stock online is both straightforward and secure for South African investors, thanks to regulated brokers that comply with local financial regulations. You can easily invest in Remgro using two main approaches: spot (cash) buying, where you own the actual shares, and trading via Contracts for Difference (CFDs), which lets you speculate on price moves with leverage. Both methods have distinct features and fees. To help you pick the best solution and the most competitive broker, we offer a clear broker comparison further down this page.

Cash buying

When you buy Remgro shares for cash, you acquire real ownership of the stock, making you a direct shareholder listed on the Johannesburg Stock Exchange (JSE). Orders are placed in rands (ZAR), and local regulated brokers typically charge a fixed commission per trade, often from R60 to R150 depending on the platform, plus small regulatory and settlement fees.

Concrete example

Concrete example:
- Current Remgro share price: 16,142 ZAR
- With an investment of $1,000 (~18,000 ZAR in June 2025), you could buy approximately 1.1 shares (including a brokerage fee of about $5 or 90 ZAR).
- ✔️ Gain scenario:
If the share price rises by 10%, your investment would now be worth around 19,800 ZAR ($1,100).
Result: +$100 gross gain, or +10% on your capital, excluding taxes.

Trading via CFD

CFD trading allows you to speculate on the price of Remgro shares without physically owning them. Instead, you enter a contract with your broker to exchange the difference in the share’s price between opening and closing. Fees for CFDs usually include the spread (difference between buy/sell price) and overnight financing costs if the trade is held for more than a day. CFDs also offer leverage, meaning you can open positions of greater value than your initial deposit.

Example

Example:
- You invest $1,000 in a CFD on Remgro shares, using 5x leverage.
- This gives you exposure worth $5,000.
- ✔️ Gain scenario:
If Remgro’s price rises by 8%, your position earns 8% × 5 = 40%. That’s a $400 gain on your $1,000 margin (before fees).

Final advice

Before investing, it’s crucial to compare brokers’ fees (commission, spread, financing) and available features to find the option that fits your strategy and budget. Both cash buying and CFD trading offer significant opportunities, but each suits different risk preferences and objectives. Ultimately, your choice should reflect whether you aim for long-term ownership and dividends, or seek to amplify short-term price trends. For detailed comparisons of regulated brokers in South Africa, see our table further down this page.

Our 7 tips for buying Remgro stock

The latest news about Remgro

Remgro’s share price surges 3.76% this week, reaching a new annual high on the JSE. In the past seven days, Remgro’s stock has recorded an intraday increase of 1.62% and now stands at 16,142 ZAR, marking a robust one-year return of 28.32%. This positive price momentum reflects growing investor confidence following the release of strong interim financial results, pushing the share above its 15-day moving average and triggering a strong buy signal from technical indicators. The current price is approaching the 52-week high of 16,499 ZAR, underscoring renewed market interest in the South African investment conglomerate.

Remgro’s half-year financials deliver a strong turnaround, beating expectations with doubled profitability. For the six months through December 2024, Remgro posted revenue of 26.4 billion ZAR, up 3.9% year-on-year, and a swing to a net profit of 3.66 billion ZAR from a prior loss. Earnings per share reversed from a 3.61 ZAR loss to a positive 6.59 ZAR, and the company reported a notably improved 14% net margin. Notably, interim dividends were raised by 20% to 96 cents per share, highlighting management’s confidence and creating fresh yield appeal for South African shareholders while cementing Remgro’s profile as a stable, income-generating stock.

Key subsidiaries Rainbow, RCL Foods, OUTsurance, and Heineken Beverages show significant operational improvement. Remgro’s portfolio has recently benefited from enhanced performance at several major local subsidiaries. Rainbow and RCL Foods have delivered stronger operational results, OUTsurance Group continues to grow its footprint in South Africa’s insurance sector, and Heineken Beverages has returned to profitability. These improvements anchor Remgro’s diversified business model, feeding through to group-level earnings, and reinforce its status as a bellwether for South African corporate investment.

Strategic deal progress continues as the Vodacom acquisition of Maziv moves forward with new extension. Remgro’s ongoing involvement in the Maziv-Vodacom deal—a key event for South Africa’s telecoms sector—has seen the transaction’s deadline extended to 13 June 2025. While the process faces regulatory scrutiny, Remgro has managed developments prudently, ensuring the group remains compliant and well-positioned for potential upside if the deal is finalized, without incurring material downside. This careful navigation of the regulatory landscape demonstrates resilience and tactical maturity in the South African context.

Remgro’s intrinsic net asset value per share increases 10.3%, signaling stronger fundamentals and optimistic outlook. The company’s calculated intrinsic NAV per share has climbed to 276.89 ZAR, up 10.3%, reflecting higher valuations across key holdings such as Rand Merchant Bank Holdings, FirstRand, and Mediclinic. This value accretion, buoyed by disciplined capital allocation strategies and a balanced, high-quality investment portfolio, underpins Remgro’s standing as a dominant player in South Africa’s investment landscape and supports sustained positive sentiment from analysts and investors alike.

FAQ

P. Laurore

Finance expert

Co-founder of HelloSafe and holder of a Master's degree in finance, Pauline has recognised expertise in personal finance, which she uses to help users better understand and optimise their financial choices. At HelloSafe, Pauline plays a key role in designing clear, educational content on savings, investments and personal finance. Passionate about financial education, Pauline strives, with every piece of content she oversees, to provide reliable, transparent and unbiased information for independent and informed financial management. To this end, she has tested over 100 trading platforms to help internet users make the right choices.